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Clinical PerspectiveWhat Is New?This was the first study that compared the association between the numbers of cardiologists per cardiovascular bed and the clinical outcomes for acute heart failure.Patients with heart failure who were admitted to hospitals with larger numbers of cardiologists per cardiovascular bed were associated with lower in‐hospital mortality and higher prescription rates for guideline‐based treatments of heart failure.What Are the Clinical Implications?Strategy for the appropriate distribution of cardiologists among hospitals or the development of better transportation system to appropriate hospitals may lead to improvements in the in‐hospital outcomes and the quality of care for heart failure.

 {#jah34385-sec-0008}

Heart failure (HF) is one of the increasing global problems and leading causes of hospitalization.[1](#jah34385-bib-0001){ref-type="ref"}, [2](#jah34385-bib-0002){ref-type="ref"}, [3](#jah34385-bib-0003){ref-type="ref"} The number of hospitalizations with HF is increasing, largely because of an increase in population size and age.[4](#jah34385-bib-0004){ref-type="ref"} The mortality from HF has slightly improved because of improved care over the past 10 years, which is probably because medical therapy and circulation devices were widely used.[5](#jah34385-bib-0005){ref-type="ref"} However, in‐hospital mortality rates from acute HF have remained at the same level in recent years, and the 30‐day readmission rate and 5‐year mortality of HF are still high.[6](#jah34385-bib-0006){ref-type="ref"}, [7](#jah34385-bib-0007){ref-type="ref"}, [8](#jah34385-bib-0008){ref-type="ref"}

To further improve the quality of treatments for HF, structural and clinical properties of the hospital, including the physician and case volumes, require more attention. Joynt et al showed that patients with HF cared for by high‐volume physicians had lower mortality rates, whereas Ross et al showed that patients with HF cared for by high case volume hospitals had lower risk of in‐hospital mortality.[9](#jah34385-bib-0009){ref-type="ref"}, [10](#jah34385-bib-0010){ref-type="ref"} Although high physician volumes led to better outcomes, how to appropriately distribute the physician resources under existing conditions is still incompletely understood. To better understand the relationships between physician resources and HF mortality, we thought that the numbers of cardiologists per cardiovascular beds would provide more information. However, there has been no study to clarify whether the larger numbers of cardiologists per cardiovascular beds would lead to better outcomes.

The aim of this study was to clarify the relationships between the number of cardiologists per cardiovascular beds and in‐hospital HF mortality.

Materials and Methods {#jah34385-sec-0009}
=====================

Source of Data and Study Patients {#jah34385-sec-0010}
---------------------------------

The data, analytic methods, and study materials will not be made available to any researchers for purposes of reproducing the results or replicating the procedure.

This was a cross‐sectional study, which used the JROAD (Japanese Registry of All Cardiac and Vascular Diseases) database and JROAD--Diagnosis Procedure Combination (DPC) discharge database.

JROAD is the institutional database, conducted by the Japanese Circulation Society. The data were collected from all training hospitals with cardiovascular beds, and the response rate was 100% each year.[11](#jah34385-bib-0011){ref-type="ref"}, [12](#jah34385-bib-0012){ref-type="ref"} We obtained the following data from the JROAD database: number of hospital beds and cardiologists, presence or absence of cardiac surgery division and coronary care unit, hospital teaching status, and annual number of operations and cardiovascular examinations. The definition of "cardiovascular beds" proposed herein is the total beds of a department of cardiology, not including cardiovascular surgery and pediatrics, on the basis of the JROAD.

JROAD‐DPC is the claim database, derived from the Japanese DPC/Per Diem Payment System. JROAD‐DPC includes patient data, such as age and sex, main diagnoses and comorbidities, drugs, diagnostic and therapeutic procedures, length of stay, and patient outcomes.[12](#jah34385-bib-0012){ref-type="ref"}, [13](#jah34385-bib-0013){ref-type="ref"} Of the overall 1620 hospitals included in the JROAD, 808 provided DPC data to the Japanese Circulation Society in 2012 and 2013.

We extracted the patients' data from JROAD and JROAD‐DPC database on the basis of the following inclusion criteria: (1) patients hospitalized in cardiovascular departments because of HF from April 1, 2012, to March 31, 2014; and (2) patients hospitalized on emergency admission. The diagnosis of HF was based on the *International Classification of Diseases, Tenth Revision* (*ICD‐10*), codes for HF (I50.0, I50.1, and I50.9). Exclusion criteria were as follows: (1) aged \<20 years; (2) hospitalized in facilities that treat \<10 patients with HF per year; and (3) missing variables.

Statistical Analysis {#jah34385-sec-0011}
--------------------

Data were presented as mean and SD for normally distributed data, median (interquartile range) for nonnormally distributed data, or absolute number (proportion) for categorical data. The patients were categorized into 4 groups by the quartiles of the numbers of cardiologists per 50 cardiovascular beds. The differences among groups were compared using either analysis of variance or Kruskal‐Wallis test for continuous variables with Bonferroni correction; or the χ^2^ test for noncontinuous and categorical variables. The main outcome was in‐hospital mortality. The association between the number of cardiologists per 50 cardiovascular beds and 30‐day mortality was analyzed using multilevel mixed‐effect logistics regression, with hospital characteristics at the first level and patient characteristics at the second level. The models were adjusted for the following covariates based on previous reports: age, sex, Charlson comorbidity index, Barthel index, New York Heart Association classification, comorbidities (hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease, and atrial fibrillation), presence of cardiac surgery division and coronary care unit, hospital teaching status, and use of ambulance. Barthel index was the assessment tool for activity of daily living. We divided Barthel index on admission into 3 groups: low (0--70), middle (75--95), and high (100), according to a past report.[14](#jah34385-bib-0014){ref-type="ref"}

We then investigated the rates of the following treatments and clinical outcomes according to the number of cardiologists per cardiovascular beds: prescription rates for medications (angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers, β blockers, and mineralocorticoid receptor antagonists), rates for cardiac rehabilitation performance and circulation device use, hospitalization costs, and the length of hospital stay. The multilevel logistic models were used to derive adjusted odds ratio of the prescription rates for medications, using the same covariates. In addition, we performed sensitivity analysis for the main outcome, including the patients without emergency hospitalization, because planned patients were taken care of by the same cardiologists and the distribution of patients with planned admission may affect the results.

A 2‐sided *P*\<0.05 was considered statistically significant. STATA, Version 14 (Stata Corp, College Station, TX) was used for the analysis.

Ethics Statement {#jah34385-sec-0012}
----------------

This study protocol was approved by the ethical committees in both the Japanese Circulation Society and Nara Medical University (Nara, Japan). The requirement for individual informed consent was waived because no information specifying individuals was included. Data anonymization of the patients' identifiers was performed in the originally provided DPC data.

Results {#jah34385-sec-0013}
=======

Patient Selection {#jah34385-sec-0014}
-----------------

From April 2012 through March 2014, we identified a total of 224 594 patients with HF in 808 hospitals. We excluded 27 919 patients hospitalized in other departments and 23 065 patients without emergency hospitalization. We included 173 610 patients with acute HF hospitalized in the cardiovascular departments. We excluded 52 patients aged \<20 years, 488 patients hospitalized in facilities treating \<10 patients with HF per year, and 18 780 patients with missing variables. Consequently, we analyzed 154 290 patients with acute HF in 770 hospitals (Figure [1](#jah34385-fig-0001){ref-type="fig"}).

![Study flow chart.](JAH3-8-e012282-g001){#jah34385-fig-0001}

Hospital Characteristics {#jah34385-sec-0015}
------------------------

The number of cardiologists per 50 cardiovascular beds (median \[interquartile range\]) was 4.4 (3.5--5.0), 6.7 (6.5--7.5), 9.7 (8.8--10.1), and 16.7 (14.0--23.8) in the first, second, third, and fourth groups, respectively (Table [1](#jah34385-tbl-0001){ref-type="table"}). As the number of cardiologists per 50 cardiovascular beds increased, the following variables also increased: number of patients with HF per facility, hospital beds and cardiologists, presence of cardiac surgery division and coronary intensive care unit, and hospital teaching status. The number of patients with HF per cardiologists was lowest in the fourth group. For each condition, larger numbers of cardiologist hospitals were more likely to provide operations such as coronary interventions, coronary artery bypass grafting, catheter ablation, and pacemaker implantation. They were also more likely to offer clinical examinations, such as echocardiography, coronary computed tomography, magnetic resonance imaging, and radioisotope scintigraphy, for all patients hospitalized at each hospital (Table [S1](#jah34385-sup-0001){ref-type="supplementary-material"}).

###### 

Hospital Characteristics by Category of Cardiologist Numbers per Cardiovascular Beds

  Characteristics                                          Total             First Group      Second Group      Third Group       Fourth Group        *P* Value
  -------------------------------------------------------- ----------------- ---------------- ----------------- ----------------- ------------------- -----------
  JCS‐certified cardiologists per 50 cardiovascular beds                                                                                              
  Median (IQR)                                             8.3 (5.7--11.8)   4.4 (3.5--5.0)   6.7 (6.5--7.5)    9.7 (8.8--10.1)   16.7 (14.0--23.8)   
  Range                                                    0.63--68.6        0.63--5.7        5.8--8.2          8.3--11.8         11.9--68.6          
  No. (%) of hospitals                                     770               201 (26)         177 (23)          203 (26)          189 (25)            
  No. of patients with HF/facilities per y                 152 (97--226)     113 (77--170)    150.5 (98--215)   166 (116--242)    186 (118--275)      \<0.001
  No. of patients with HF/cardiologists per y              43 (28--66)       59 (41--86)      51 (34--73)       40 (28--65)       26 (13--42)         \<0.001
  Hospital beds                                            394 (287--547)    300 (210--366)   372 (300--466)    403 (307--539)    590 (413--749)      \<0.001
  Cardiovascular beds                                      35 (28--45)       38 (30--48)      35 (30--45)       33 (28--40)       35 (25--45)         0.03
  JCS‐certified cardiologists                              4 (3--6)          3 (2--3)         4 (3--5)          4 (3--6)          7 (5--13)           \<0.001
  JCS‐certified and non--JCS‐certified cardiologists       5 (4--8)          3 (2--4)         5 (4--6)          7 (5--8)          11 (8--19)          \<0.001
  Cardiac surgery facilities, %                            59                39               51                64                83                  \<0.001
  Cardiac intensive care units, %                          82                68               84                86                90                  \<0.001
  Hospital teaching status, %                              82                67               81                88                91                  \<0.001

Continuous variables were expressed as median (IQR) for skewed distributed data. Kruskal‐Wallis test was used to test for mean differences across groups. Categorical variables were presented as frequencies or percentages and were compared using the χ^2^ test. HF indicates heart failure; IQR, interquartile range; JCS, Japanese Circulation Society.
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Patient Characteristics {#jah34385-sec-0016}
-----------------------

Approximately 57% of the patients were admitted to the hospitals in the third or fourth groups. By age, they were slightly younger in the larger numbers of cardiologists' groups. There were minimal differences in Charlson comorbidity index, activities of daily living on admission, and New York Heart Association classification. Diabetes mellitus and dyslipidemia were common in the larger numbers of cardiologists' groups, whereas atrial fibrillation and chronic obstructive pulmonary disease were common in the smaller numbers of cardiologists' groups (Table [2](#jah34385-tbl-0002){ref-type="table"}).

###### 

Patient Characteristics by the Number of Cardiologists per Cardiovascular Beds

  Characteristics                                          Total             First Group      Second Group     Third Group       Fourth Group        *P* Value
  -------------------------------------------------------- ----------------- ---------------- ---------------- ----------------- ------------------- -----------
  JCS‐certified cardiologists per 50 cardiovascular beds                                                                                             
  Median (IQR)                                             8.3 (5.7--11.8)   4.4 (3.5--5.0)   6.7 (6.5--7.5)   9.7 (8.8--10.1)   16.7 (14.0--23.8)   
  Range                                                    0.63--68.6        0.63--5.7        5.8--8.2         8.3--11.8         11.9--68.6          
  No. (%) of patients                                      150 890           29 214 (19)      35 911 (24)      45 526 (30)       40 239 (27)         
  Age, y                                                   79±12             81±11            79±12            79±12             77±12               \<0.001
  Male sex, %                                              52                48               50               52                54                  \<0.001
  Charlson comorbidity index                               2 (1--3)          2 (1--3)         2 (1--3)         2 (1--3)          2 (1--3)            \<0.001
  Barthel index, %                                                                                                                                   
  Low (0--70)                                              65                66               64               65                64                  \<0.001
  Middle (75--95)                                          9                 10               10               10                9                   
  High (100)                                               26                24               26               25                27                  
  NYHA classification, %                                                                                                                             
  I                                                        7                 6                6                7                 7                   \<0.001
  II                                                       26                25               26               27                25                  
  III                                                      34                37               34               32                34                  
  IV                                                       33                34               34               33                34                  
  Comorbidities, %                                                                                                                                   
  Hypertension                                             53                52               53               53                53                  \<0.001
  Diabetes mellitus                                        34                31               33               34                38                  \<0.001
  Dyslipidemia                                             37                31               35               37                44                  \<0.001
  Chronic kidney disease                                   12                12               12               11                12                  \<0.001
  Atrial fibrillation                                      28                30               28               28                27                  \<0.001
  COPD                                                     12                14               12               11                11                  \<0.001
  Ambulance use, %                                         40                34               39               42                44                  \<0.001

Continuous variables were expressed as mean±SD for normally distributed data or median (IQR) for skewed distributed data. Analysis of variance or Kruskal‐Wallis test was used to test for mean differences across groups. Categorical variables are presented as frequencies or percentages and were compared using the χ^2^ test. COPD indicates chronic obstructive pulmonary disease; IQR, interquartile range; JCS, Japanese Circulation Society; NYHA, New York Heart Association.
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In‐Hospital Mortality {#jah34385-sec-0017}
---------------------

Crude in‐hospital mortality rates decreased as the number of cardiologists per 50 cardiovascular beds increased: 12% (N=3344), 10% (N=3620), 9% (N=4058), and 7% (N=2848) for the first, second, third, and fourth groups (Table [3](#jah34385-tbl-0003){ref-type="table"}). Unadjusted odds ratios (95% CIs) for in‐hospital mortality for HF were 0.86 (0.78--0.94; *P*\<0.001), 0.74 (0.67--0.81; *P*\<0.001), and 0.58 (0.52--0.63; *P*\<0.001) for the second, third, and fourth groups, respectively. The estimate of variance for the mixed model was 0.49, with an SE of 0.02 (*P*\<0.001 for the likelihood‐ratio test between mixed‐effect model and logistic regression model). Adjusted analysis showed that increased number of cardiologists per cardiovascular beds was associated with reduced in‐hospital rates of deaths in patients with acute HF. The adjusted odds ratios (95% CIs) for in‐hospital mortality were 0.92 (0.81--1.04; *P*=0.18), 0.81 (0.71--0.91; *P*\<0.001), and 0.68 (0.59--0.77; *P*\<0.001) for the second, third, and fourth groups, respectively (Figure [2](#jah34385-fig-0002){ref-type="fig"}). In the sensitivity analysis, we additionally included 3679, 4215, 5581, and 7310 patients with planned admission in the first, second, third, and fourth groups, respectively. The sensitivity analysis showed the robustness of the results (adjusted odds ratios (95% CIs) for in‐hospital mortality: 0.92 \[0.82--1.04; *P*=0.21\], 0.80 \[0.71--0.90; *P*\<0.001\], and 0.68 \[0.60--0.78; *P*\<0.001\] for the second, third, and fourth groups, respectively).

###### 

Treatments and Outcomes by the Numbers of Cardiologists per Cardiovascular Beds

  Variable                                                 Total                 First Group           Second Group          Third Group           Fourth Group          *P* Value
  -------------------------------------------------------- --------------------- --------------------- --------------------- --------------------- --------------------- -----------
  JCS‐certified cardiologists per 50 cardiovascular beds                                                                                                                 
  Median (IQR)                                             8.3 (5.7--11.8)       4.4 (3.5--5.0)        6.7 (6.5--7.5)        9.7 (8.8--10.1)       16.7 (14.0--23.8)     
  Range                                                    0.63--68.6            0.63--5.7             5.8--8.2              8.3--11.8             11.9--68.6            
  No. (%) of patients                                      150 890               29 214 (19)           35 911 (24)           45 526 (30)           40 239 (27)           
  Medication, %                                                                                                                                                          
  ACE inhibitors or ARBs                                   60                    56                    60                    60                    67                    \<0.001
  β Blockers                                               56                    48                    53                    57                    65                    \<0.001
  Mineralocorticoid receptor antagonists                   48                    46                    46                    48                    53                    \<0.001
  Calcium channel blockers                                 37                    34                    35                    36                    39                    \<0.001
  Statins                                                  29                    24                    27                    29                    35                    \<0.001
  Oral hypoglycemic agents                                 19                    17                    19                    19                    21                    \<0.001
  Loop diuretics                                           88                    86                    88                    87                    89                    \<0.001
  Thiazide                                                 11                    9                     10                    11                    13                    \<0.001
  Tolvaptan                                                12                    10                    12                    11                    12                    \<0.001
  Cardiac rehabilitation                                   25                    19                    20                    25                    34                    \<0.001
  Device use and operation, %                                                                                                                                            
  Respirator                                               19                    15                    18                    19                    23                    \<0.001
  IABP                                                     0.8                   0.3                   0.7                   1                     1.2                   \<0.001
  VA‐ECMO                                                  0.1                   0.1                   0.1                   0.1                   0.2                   \<0.001
  CRRT                                                     1.5                   1.3                   1.5                   1.4                   1.6                   \<0.001
  PCI                                                      4.3                   3.5                   3.9                   4.5                   4.9                   \<0.001
  Ablation                                                 0.2                   0.1                   0.2                   0.2                   0.3                   \<0.001
  Length of hospital stay, days                            18 (11--27)           19 (12--31)           18 (12--29)           17 (11--26)           17 (11--25)           \<0.001
  Hospitalization cost, \$                                 7133 (4786--11 156)   6771 (4543--10 522)   6890 (4626--10 709)   7141 (4808--11 126)   7627 (5099--12 121)   \<0.001
  Discharge destination, %                                                                                                                                               
  Home                                                     78                    75                    78                    79                    80                    \<0.001
  Other hospitals                                          9                     8                     8                     9                     10                    
  Nursing homes                                            4                     5                     4                     3                     2                     
  In‐hospital death                                        10                    12                    10                    9                     7                     

Continuous variables were expressed as median (IQR) for skewed distributed data. Kruskal‐Wallis test was used to test for mean differences across groups. Categorical variables are presented as frequencies or percentages and were compared using the χ^2^ test. ACE indicates angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker; CRRT, continuous renal replacement therapy; VA‐ECMO, venoarterial‐extracorporeal membrane oxygenation; IABP, intra‐aortic balloon pumping; IQR, interquartile range; JCS, Japanese Circulation Society; PCI, percutaneous coronary intervention. \$1=¥110.
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![The number of cardiologists and in‐hospital mortality for acute heart failure. Model includes age (per 10 years), sex, Charlson comorbidity index, New York Heart Association classification, hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease, atrial fibrillation, cardiac surgery, coronary care unit, hospital teaching status, and ambulance use. OR indicates odds ratio.](JAH3-8-e012282-g002){#jah34385-fig-0002}

Treatments for HF {#jah34385-sec-0018}
-----------------

The prescription rates of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers, βlockers, and mineralocorticoid receptor antagonists were higher in the larger numbers of cardiologists' groups (Table [3](#jah34385-tbl-0003){ref-type="table"}). The adjusted odds ratios for in‐hospital medical treatments for patients with HF were as follows. For the second, third, and fourth groups, adjusted odds ratios (95% CIs) for β‐blocker use were 1.09 (0.97--1.22; *P*=0.15), 1.23 (1.09--1.38; *P*\<0.001), and 1.59 (1.41--1.81; *P*\<0.001), respectively. For angiotensin‐converting enzyme inhibitor use, the 3 odds ratios (95% CIs) were 1.04 (0.92--1.17; *P*=0.54), 1.03 (0.91--1.16; *P*=0.62), and 1.38 (1.20--1.58; *P*\<0.001), respectively. For mineralocorticoid receptor antagonist use, these odds ratios (95% CIs) were 0.97 (0.87--1.08; *P*=0.59), 1.08 (0.97--1.21; *P*=0.17), and 1.27 (1.13--1.44; *P*\<0.001), respectively (Table [4](#jah34385-tbl-0004){ref-type="table"}).

###### 

Adjusted In‐Hospital Medical Treatments for Patients With HF

  Group    Numbers of Cardiologists per 50 Cardiovascular Beds   β Blockers   ACE Inhibitors or ARBs   MRAs                                                        
  -------- ----------------------------------------------------- ------------ ------------------------ --------- ------ ------------ --------- ------ ------------ ---------
  First    0.63--5.7                                             1            Reference                          1      Reference              1      Reference    
  Second   5.8--8.2                                              1.09         0.97--1.22               0.15      1.04   0.92--1.17   0.54      0.97   0.87--1.08   0.59
  Third    8.3--11.8                                             1.23         1.09--1.38               \<0.001   1.03   0.91--1.16   0.62      1.08   0.97--1.21   0.17
  Fourth   11.9--68.6                                            1.59         1.41--1.81               \<0.001   1.38   1.20--1.58   \<0.001   1.27   1.13--1.44   \<0.001

Model includes age (per 10 years), sex, Charlson comorbidity index, Barthel index, New York Heart Association classification, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease, atrial fibrillation, cardiac surgery, coronary care unit, hospital teaching status, and ambulance use. ACE indicates angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker; HF, heart failure; MRA, mineralocorticoid receptor antagonist; OR, odds ratio.

John Wiley & Sons, Ltd

A larger number of cardiologists was associated with the higher prescription rate of cardiac rehabilitation, the use of circulation devices (eg, respirators, intra‐aortic balloon pump, and percutaneous cardiopulmonary support system), and operations (eg, percutaneous coronary intervention and catheter ablation). These procedures increased as the numbers of cardiologists per 50 cardiovascular beds increased (Table [3](#jah34385-tbl-0003){ref-type="table"}).

Hospitalization Costs and the Length of Hospital Stay {#jah34385-sec-0019}
-----------------------------------------------------

In comparison with the smaller number of cardiologists' group, the hospitalization costs in the larger number of cardiologists' group was slightly higher (median hospitalization costs were \$6771 \[¥744 834\], \$6890 \[¥757 985\], \$7141 \[¥785 572\], and \$7627 \[¥839 057\] for the first to fourth groups, respectively). The length of hospital stay was almost the same among groups (Table [3](#jah34385-tbl-0003){ref-type="table"}).

Discussion {#jah34385-sec-0020}
==========

In this study, we demonstrated that the numbers of cardiologists per 50 cardiovascular beds were associated with lower in‐hospital mortality and higher prescription of guideline‐based medical therapy for patients with HF. These findings suggest that optimizing the number of cardiologists per cardiovascular beds is needed, and these results provide useful information for optimizing physician resources to reduce the mortality caused by HF.

This was the first study that compared the association between the numbers of cardiologists per cardiovascular bed and the clinical outcomes. Our results are generally consistent with previous studies, which investigated the effect of absolute numbers of physicians on quality of treatment. Although the present study is an observational study and, thus, it is impossible to clarify the cause‐effect relationship, there may be some advantages of a larger number of cardiologists per cardiology beds and some disadvantages of a smaller number.

An earlier study[10](#jah34385-bib-0010){ref-type="ref"} showed that the mortality in patients with HF who were admitted to hospitals with higher physician volume per hospital was lower, probably because physicians in high‐volume hospitals may be more skilled in decision making about medication use. Other studies showed that patients admitted with acute HF were recommended to be seen for cardiology services; and the larger numbers of cardiologists per hospital beds led to better therapeutic practices in the hospitals with more cardiologists.[15](#jah34385-bib-0015){ref-type="ref"}, [16](#jah34385-bib-0016){ref-type="ref"}, [17](#jah34385-bib-0017){ref-type="ref"} In fact, in our study, patients with HF admitted to larger numbers of cardiologist hospitals more commonly underwent intensive treatments, such as an artificial respirator, intra‐aortic balloon pump, and percutaneous coronary intervention. These treatments might be related to better short‐term outcomes in patients with HF. In addition, given that contemporary patients with HF are elderly people with multiple comorbidities, multidisciplinary medical treatment and care should be provided by the heart team, consisting of healthcare professionals from varied fields. Generally, in Japan, the heart team medical service is being developed in large hospitals, which usually comprise many cardiologists.

We showed that the prescription rates for guideline‐based medical treatments, such as angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers, β blockers, and MRAs, were lower in the small numbers of cardiologists per cardiovascular beds groups, even after adjustment for patient and hospital characteristics. Guideline‐based medical therapies led to better long‐term outcomes for patients with HF, and are strongly recommended for the smaller numbers of cardiologists per cardiology beds groups.[18](#jah34385-bib-0018){ref-type="ref"}, [19](#jah34385-bib-0019){ref-type="ref"} We showed that the number of patients with HF per cardiologists was higher in the smaller number of cardiologists' groups than that in the larger number of cardiologists' groups, which may lead to heavy workload and reduce the quality of care.

In summary, our study showed that many cardiologists per cardiovascular beds leads to significantly reduced in‐hospital mortality caused by acute HF, which was consistent with the results of past studies. It might be difficult to increase the absolute number of cardiologists soon; however, an alternative can be considered in terms of strategy for appropriate distribution of cardiologists among hospitals or the development of a better transportation system to appropriate hospitals for patients with HF, which may lead to improvements in the in‐hospital outcomes and the quality of care for HF.

Study Limitations {#jah34385-sec-0021}
-----------------

Our study has several limitations. First, this was an observational study using the administrative database, which included ≈50% of Japanese Circulation Society--certified hospitals in Japan.[20](#jah34385-bib-0020){ref-type="ref"} Second, the JROAD‐DPC did not include detailed patients' characteristics, such as laboratory and physiological data. Third, we could not investigate the long‐term mortality and accurate rehospitalization rates in this study. The prescription rates for medications and cardiac rehabilitation were higher in the larger numbers of cardiologists' groups, which may result in better long‐term outcomes.

Conclusions {#jah34385-sec-0022}
===========

Patients with HF who were admitted to hospitals with larger numbers of cardiologists per cardiovascular bed were associated with lower in‐hospital mortality and higher prescription rates for guideline‐based treatments of HF.

Disclosures {#jah34385-sec-0023}
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**Table S1.** Hospital Characteristics by Category of Cardiologist Number Per Cardiovascular Beds
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Click here for additional data file.
